Ventana Developing Companion Diagnostic For Novartis’ Gleevec Cancer Drug
This article was originally published in The Gray Sheet
Executive Summary
Ventana Medical Systems expects to submit a premarket approval application by early next year for a c-kit diagnostic for use with Novartis' drug Gleevec (imatinib mesylate)